Zacks lowered shares of Lannett Co. (NYSE:LCI) from an outperform rating to a neutral rating in a research report released on Monday morning, AmericanBankingNews.com reports. Zacks currently has $37.80 price objective on the stock. Zacks has also modified their ratings on a number of other healthcare stocks in the few days. The firm upgraded shares […]
Lannett Co. Downgraded to “Neutral” at Zacks (LCI) is a post from: Zolmax
The post Lannett Co. Downgraded to “Neutral” at Zacks (LCI) appeared first on Zolmax.